@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-MSSJ-MSJ00030 a mbo:MassSpectrum ;
    dcterms:creator "CASMI2013 organizers" ;
    dcterms:date "2016-01-19 (Created 2014-07-24)"^^xsd:date ;
    dcterms:identifier "MSBNK-MSSJ-MSJ00030" ;
    dcterms:license <https://creativecommons.org/licenses/by-sa/4.0/> ;
    dcterms:rights "Mass Spectrometry Society of Japan under CC BY-SA" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Dionex U3000 and Exactive Orbitrap (Thermofisher Scientific)" ;
            mbo:collision_energy "20 V" ;
            mbo:column_name "L-column 2 ODS" ;
            mbo:flow_gradient "0 to 5 min, a linear increase from 10% to 100% B 5 to 10 min, hold at 100% B and 10 to 15 min, equilibration at 10% B" ;
            mbo:flow_rate "0.2 mL/min" ;
            mbo:instrument_type "LC-ESI-ITFT" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS" ;
            mbo:solvent "A methanol containing 2 mM formate",
                "B water containing 2 mM formate" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Ofloxacin" ;
            mbo:ch_compound_class "Non-Natural Product" ;
            mbo:ch_exact_mass 3.611438e+02 ;
            rdfs:seeAlso chemspider:4422,
                pubchem:CID4583 ;
            schema:inChI "InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)" ;
            schema:inChIKey inchikey:GSDSWSVVBLHKDQ-UHFFFAOYSA-N ;
            schema:molecularFormula "C18H20FN3O4" ;
            schema:name "Ofloxacin" ;
            schema:smiles "CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O" ] ;
    mbo:has_peak [ mbo:intensity 1.377e+03 ;
            mbo:mz 5.505485e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 60 ],
        [ mbo:intensity 1.616e+03 ;
            mbo:mz 9.508618e+01 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 70 ],
        [ mbo:intensity 4.327e+03 ;
            mbo:mz 9.706544e+01 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 188 ],
        [ mbo:intensity 3.284e+03 ;
            mbo:mz 1.49024e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 143 ],
        [ mbo:intensity 4.203e+03 ;
            mbo:mz 1.975857e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 183 ],
        [ mbo:intensity 2.586e+03 ;
            mbo:mz 2.250439e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 113 ],
        [ mbo:intensity 2.474e+03 ;
            mbo:mz 2.611045e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 108 ],
        [ mbo:intensity 1.64e+03 ;
            mbo:mz 2.990629e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 71 ],
        [ mbo:intensity 2.2934e+04 ;
            mbo:mz 3.181625e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 3.708e+03 ;
            mbo:mz 3.191659e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 162 ],
        [ mbo:intensity 1.6428e+04 ;
            mbo:mz 3.621525e+02 ;
            mbo:peak_sequential_number 19 ;
            mbo:relative_intensity 716 ],
        [ mbo:intensity 1.83e+03 ;
            mbo:mz 6.503922e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 80 ],
        [ mbo:intensity 2.814e+03 ;
            mbo:mz 3.631559e+02 ;
            mbo:peak_sequential_number 20 ;
            mbo:relative_intensity 123 ],
        [ mbo:intensity 1.964e+03 ;
            mbo:mz 6.705487e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 86 ],
        [ mbo:intensity 1.302e+03 ;
            mbo:mz 6.903413e+01 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 57 ],
        [ mbo:intensity 4.04e+03 ;
            mbo:mz 6.907052e+01 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 176 ],
        [ mbo:intensity 3.852e+03 ;
            mbo:mz 7.905487e+01 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 168 ],
        [ mbo:intensity 4.768e+03 ;
            mbo:mz 8.107052e+01 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 208 ],
        [ mbo:intensity 1.859e+03 ;
            mbo:mz 9.105488e+01 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 81 ],
        [ mbo:intensity 2.644e+03 ;
            mbo:mz 9.50498e+01 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 115 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ] ;
    mbo:pk_num_peak 20 ;
    mbo:pk_splash "splash10-02t9-5119000000-4b2d5bb992ab6e793c4f" ;
    rdfs:comment "CASMI2013 Challenge_16 MS1 data, retention time = 3.7 min" ;
    skos:definition "Ofloxacin; LC-ESI-ITFT; MS; Positive; CE 20 V" .

